Table of Contents
HIV-1 Resistance Testing in Drug Development
Introduction
Implications of HIV Drug Resistance (1)
Implications of HIV Drug Resistance (2)
What are some current limitations?
HIV Resistance Testing in Drug Development: Meeting Goals
Development of Meeting
HIV Resistance Collaborative Group Representation
Federal Register Announcement
Meeting Format
Objectives - Session 1: Resistance Technology
Objectives - Session 2: Clinical Validation
Objectives - Session 3: Practical Considerations
Objectives - Session 4: Potential Roles in Drug Development
Acknowledgments
|
Author: Heidi Jolson, M.D., M.P.H.
|